So MAPS embarked on a many years-extensive work to confirm which the drug had advantage as a drugs, elevating $a hundred and forty million from donors to purchase scientific trials. The Firm formed what is now Lykos a decade ago like a public-gain Company, in anticipation that MDMA-assisted therapy would get FDA approval and begin to enjoy taxable